Advanced search
Publication Cover
Acta Oncologica Volume 29, 1990 - Issue 3
Journal homepage
169
Views
0
CrossRef citations to date
0
Altmetric
Original Article

The Design of Advanced Breast Cancer Trials New approaches

S. C. A. Fraser Departments of Surgery, and Radiotherapy, King's College School of Medicine and Dentistry, Rayne Institute, London, England
,
S. R. Ebbs Departments of Surgery, and Radiotherapy, King's College School of Medicine and Dentistry, Rayne Institute, London, England
,
H. J. Dobbs Departments of Surgery, and Radiotherapy, King's College School of Medicine and Dentistry, Rayne Institute, London, England
,
L. J. Fallowfield Departments of Surgery, and Radiotherapy, King's College School of Medicine and Dentistry, Rayne Institute, London, England
&
M. Baum Departments of Surgery, and Radiotherapy, King's College School of Medicine and Dentistry, Rayne Institute, London, England
Pages 397-400 | Accepted 07 Jan 1990, Published online: 08 Jul 2009

References

  • Henderson I C. Breast cancer: diagnosis and management, G Bonadonna. Wiley. 1984; 247–80, 13
  • Baum M, Priestman T, West R R, Jones E M. A comparison of subjective responses in a trial comparing endocrine with cytotoxic treatment in advanced carcinoma of the breast. Eur J Cancer 1980, Suppl 1: 223–6
  • A'Hern R P, Ebbs S R, Baum M. Does chemotherapy improve survival in advanced breast cancer? A statistical overview. Br J Cancer 1988; 57: 615–8
  • Ebbs S R, Saunders J A, Graham H, A'Hern R P, Bates T, Baum M. Advanced breast cancer. A randomised trial of epidoxorubicin at two different dosage and two administration systems. Acta Oncol 1989; 28: 887–92
  • Bonadonna G, Van Oosterom A. Treatment of advanced breast cancer; workshop report. Eur J Cancer Clin Oncol 1983; 19: 1779–81
  • Mattson W, Borgström S, Landberg T. A weekly schedule of low-dose doxorubicin in treatment of advanced breast cancer. Clin Ther 1982; 5: 193–203
  • Gundersen S, Kvinnsland S, Klepp O, et al. Weekly Adriamycin versus VAC in advanced breast cancer. A randomised trial. Eur J Cancer Clin Oncol 1982; 22: 1431–4
  • Hurteloup P, Ganzina F. Clinical studies with new anthracyclines: epirubicin, idarubicin, esorubicin. Drugs Exp Clin Res 1986; 12: 233–46
  • Hunt S M, McEwen J, McKenna S P. Measuring health status: a new tool for clinicians and epidemiologists. J R Coll Gen Pract 1985; 35: 185–8
  • Priestman T J, Baum M. Evaluation of quality of life in patients receiving treatment for advanced breast cancer. Lancet 1976; 1: 899–901
  • Guyatt G H, Bombardier C, Tugwell P X. Measuring disease-specific quality of life in clinical trials. Can Med Assoc J 1986; 134: 889–95
  • Clement-Jones V. Cancer and beyond: the formation of BACUP. Br Med J 1985; 291: 1021–3
  • Kalton G, Schuman H. The effect of the question on survey responses: a review. J R Stat Soc 1982; 145: 42–73

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.